Lawrence Fong, MD
University of California, San Francisco
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Lawrence Fong, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:40 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04064190 · Vactosertib with Durvalumab in Urothelial Carcinoma Failing Checkpoint InhibitionMedPacto, Inc. · withdrawn · Urothelial Carcinoma Recurrent, Advanced Urothelial Carcinoma · principal investigator
- Ph2NCT03007719 · Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1Lawrence Fong · terminated · Bladder Cancer · principal investigator
- Ph2NCT02506114 · Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate CancerLawrence Fong · terminated · Prostatic Neoplasms · principal investigator
- Ph2NCT02451423 · Neoadjuvant Atezolizumab in Localized Bladder CancerLawrence Fong · completed · Carcinoma, Transitional Cell · principal investigator
- Ph1NCT01823978 · Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate CancerBellicum Pharmaceuticals · completed · Castrate Resistent Prostate Cancer · principal investigator
- Ph2NCT01804465 · Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate CancerUniversity of California, San Francisco · completed · Prostate Cancer · principal investigator
- Ph2NCT01530984 · Ipilimumab and GMCSF Immunotherapy for Prostate CancerLawrence Fong · withdrawn · Prostate Cancer · principal investigator
- Ph1NCT00305669 · GM-CSF Before Surgery in Treating Patients With Localized Prostate CancerUniversity of California, San Francisco · completed · Prostate Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Immunotherapy of human bladder cancerR01CA194511 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Lawrence Fong · fiscal years 2015 to 2019Named on NCT02451423
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.